Skip to content
Introducing a stable probiotic + vitamin C chew tab

Press release -

Introducing a stable probiotic + vitamin C chew tab

Chr. Hansen’s probiotic experts will be in place when the doors open to this year’s Vitafoods Europe on May 22. Chr. Hansen’s entire probiotic range will be on display, including a brand new chewable tablet combining probiotics and vitamin C.

“We are bringing our complete portfolio of probiotic solutions with documented effect to Vitafoods Europe so there will be interesting offerings to see for dietary supplement producers, pharmaceutical companies or manufacturers of infant formula,” promises Charlotte Beyerholm, Marketing Manager, Human Health & Nutrition.

“In particular, we are looking forward to showcase our new combination product. Our application expertise includes an extensive technology platform that makes it possible to combine probiotics with other ingredients. Our new probiotic chewable tablet combines Lactobacillus L. casei 431® and vitamin C and is an ideal combination for immune support,” Charlotte Beyerholm says.

Overcoming application challenges
On May 23, Chr. Hansen will be hosting a Supplier Seminar focusing on the application challenges of probiotics. At the seminar, Chr. Hansen will share its extensive application experience and cover subjects such as stability, dosage forms and ingredient combinations.


Vitafoods Europe 2012 takes place May 22-24 at ‘Palexpo’ in Geneva, Switzerland. Meet Chr. Hansen’s probiotic experts at booth no. 2140 and have their take on how Chr. Hansen’s probiotics will add value to products.

Go to our Vitafoods website for further details

Topics


Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.

Contacts

Helle Rexen

Helle Rexen

Press contact Media relations officer +45 20 74 28 40

About us

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.

Chr. Hansen Holding A/S

Boege Allé 10-12
DK-2970 Hoersholm
Denmark